Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for neurofibromatosis, type IV, of Riccardi has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
175 publications have been identified in PubMed for neurofibromatosis, type IV, of Riccardi. Research spans Epidemiology / Natural History (25%), Clinical Trial Publication (22%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 44 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
Online Mendelian Inheritance in Man
Clinical study results | 39 | 22% |
Research summaries | 32 | 18% |
Patient case studies | 25 | 14% |
Laboratory research | 20 | 11% |
Testing and diagnosis research | 7 | 4% |
New treatment approaches | 6 | 3% |
Other research | 2 | 1% |
Fuentes Bolanos NA (2026). [PMID: 41457435](https://pubmed.ncbi.nlm.nih.gov/41457435/). *Cancer*. [Epidemiology / Natural History]
Li H (2026). [PMID: 41564118](https://pubmed.ncbi.nlm.nih.gov/41564118/). *PLoS One*. [Basic Science / Preclinical]
Hashimoto S (2026). [PMID: 40883188](https://pubmed.ncbi.nlm.nih.gov/40883188/). *J Orthop Sci*. [Clinical Trial Publication]
Garner R (2026). [PMID: 42116902](https://pubmed.ncbi.nlm.nih.gov/42116902/). *Surg Neurol Int*. [Review / Meta-Analysis]
Koyutourk B (2026). [PMID: 42065819](https://pubmed.ncbi.nlm.nih.gov/42065819/). *J Community Genet*. [Epidemiology / Natural History]
Boitez P (2026). [PMID: 41411884](https://pubmed.ncbi.nlm.nih.gov/41411884/). *Ann Dermatol Venereol*. [Clinical Trial Publication]
Angelova-Toshkina D (2026). [PMID: 42012601](https://pubmed.ncbi.nlm.nih.gov/42012601/). *Mol Cell Pediatr*. [Review / Meta-Analysis]
Mentzel T (2026). [PMID: 41790207](https://pubmed.ncbi.nlm.nih.gov/41790207/). *Pathologie (Heidelb)*. [Review / Meta-Analysis]
Sanikommu S (2026). [PMID: 42176397](https://pubmed.ncbi.nlm.nih.gov/42176397/). *Clin Neurol Neurosurg*. [Review / Meta-Analysis]
Kim A (2026). [PMID: 41504652](https://pubmed.ncbi.nlm.nih.gov/41504652/). *Clin Cancer Res*. [Clinical Trial Publication]